Doc. 2.09-0.5

17th Stop TB Coordinating Board Meeting

November 2009

proposed list of invitees

Chairs, Stop TB Working Groups

DOTS Expansion Working Group and

Chair of STAG

Dr Jeremiah Muhwa Chakaya

Technical Expert

National Leprosy and TB Programme

Ministry of Health

P.O. Box 20781

Nairobi

Kenya

TB/HIV Working Group

Dr Diane V. Havlir

Professor of Medicine and

Chief of the HIV/AIDS Division and

Positive Health Program

University of California

Building 80, Ward 84

995 Potrero Ave

94110 - San Francisco, California

United States of America

MDR-TB Working Group

Dr Catharina (Kitty) Lambregts

-van Weezenbeek

KNCV Tuberculosis Foundation

PO Box 146

2501 CC The Hague

The Netherlands

Working Group on New TB Vaccines

Dr Michel Greco

Independent Vaccine Expert

Parteurop

41 quai Fulchiron

69005 - Lyon

France

Global Laboratory Initiative Working Group

Dr John Ridderhof

Centers for Disease Control

1600 Clifton Road

Atlanta, GA30333

United States of America

Working Group on New TB Diagnostics

Dr Giorgio Roscigno

Chief Executive Officer

Foundation for Innovative New Diagnostics

(FIND)

16, avenue de Budé

Geneva

Switzerland

Madhukar Pai, MD, PhD

Co-Chair

Working Group on New TB Diagnostics

Assistant Professor & CIHR New In IIvestigator

Dept. of Epidemiology, Biostatistics
& Occupational Health

McGillUniversity

Working Group on new TB Drugs

Dr Mel Spigelman

Global Alliance for TB Drug Development

40 Wall Street

10005 - New York, NY, NY

United States of America

Regional Representatives

African Region

Dr Mphu Ramatlapeng

Minister of Health

Ministry of Health

Lesotho

American Region

Dr Meliton Arce Rodriguez

Deputy Minister of Health

Ministry of Health

Av. Salaverry cdra.8

Jesus Maria, Lima

Peru

Eastern Mediterranean Region

Dr Faizullah Kakar(unable to attend)

Deputy Minister of Policy, Planning and Preventive Medicine

Ministry of Public Health

Afghanistan

Great Masoud Road

Kabul

Afghanistan

Represented by:

S.E. Mr Abdallah Abdillahi Miguil

Minister of Health

Djibouti

European Region

Dr Tonka Varleva

Director

Prevention and Control of HIV/AIDS &
TB Directorate

Ministry of Health

Bulgaria

South-East Asia Region

Ms K.Sujatha Rao (unable to attend)

Secretary

Health and Family Welfare

Government of India

Nirman Bhavan

New Delhi 110011

Western Pacific Region

Dr Nobukatsu Ishikawa(unable to attend)

Director

Research Institute for TB

Japan Anti-Tuberculosis Association (JATA)

3-1-24 Matsuyama, Kiyose

204 0022 - Tokyo

Japan

Represented by:

Dr Akira Shimouchi

Vice Director

Research Institute for TB

Japan Anti-Tuberculosis Association (JATA)

High-TB-burden Countries

China

Dr Xiao Donglou

Deputy Director General

Bureau of Disease Prevention and Control

Ministry of Health

1, Xi Zhi Men Wai Nan Lu

People's Republic of China

Myanmar

Professor Kyaw Myint (unable to attend)

Minister of Health

Ministry of Health

Myanmar

Represented by:

Dr Win Myint

Director General

Department of Health

Ministry of Health

South Africa

Represented by:

Dr Yogan Pillay (unable to attend)

Deputy Director-General

Department of Health

Private Bag X399

Pretoria

0001 South Africa

Tanzania

Professor DavidH. Mwakyusa

Minister for Health and

Social Welfare

Ministry of Health and Social Welfare

PO Box 9083

Dar es Salaaam

Republic of Tanzania

Multi-lateral Organizations

Global Fund to Fight Aids, TB and Malaria

Dr Rifat Atun

Director

Strategy, Performance & Evaluation Cluster

Switzerland

United Nations Programme on HIV/AIDS

Dr Catherine Hankins

Chief Scientific Adviser to UNAIDS

and Associate Director

Department of Evidence,

Monitoring and Policy

United Nations Programme on HIV/AIDS

20 avenue Appia, CH 1211

Geneva 27

Switzerland

World Health Organization

Dr Mario Raviglione

Director, STB Department

HIV/AIDS, Tuberculosis and Malaria (HTM)

World Health Organization (WHO)

20, avenue Appia

Geneva 271211

Switzerland

World Bank

Mr Julian Schweitzer(unable to attend)

Director of Health, Nutrition and Population

Human Development Network

The World Bank

1818 H Street, NW

Washington, DC20433

United States of America

Represented by:

Ms. Montserrat Meiro-Lorenzo

Senior Public Health Specialist

The World Bank

Japan — Ministry of Health, Labour

and Welfare

Dr Masato Mugitani (unable to attend)

Assistant Minister for Global Health, Minister’s Secretariat

Ministry of Health, Labour and Welfare

1-2-2, Kasumigaseki, Chiyoda-ku

Tokyo 100-8916, JAPAN

Represented by:

Dr Mari Nagai

Deputy Director

The Netherlands

Dr Marja Esveld

Senior Policy Advisor - Health
Gender and Civil Society Department(DSI/SB)
Ministry of Foreign Affairs
PO Box 20061
2500 EB The Netherlands

United States Agency for International Development (USAID)

Ms Irene Koek (Chair)

Chief, Infectious Diseases Division

Office of Health and Nutrition

RonaldReaganBuilding

G/PHN/HN/EH

3.07-75M, 3rd floor, RRB

20523-3700 WashingtonD.C.

United States of America

Foundations

Bill Melinda Gates Foundation

Dr Peter M. Small (unable to attend)
Senior Program Officer, Tuberculosis
Global Health Program

PO Box 23350
Seattle, WA98102

United States of America

Represented by:

Mr Michael Kimerling

Senior Program Officer, Tuberculosis

Global Health Program

The Gates Foundation

Donors

Canadian International Development Agency (CIDA)

Dr Ernest R. Loevinsohn

Director-General

Program Against Hunger, Malnutrition

and Disease

Multilateral Programs Branch

200, Promenade du Portage

Hull, QuebecK1A 0G4, Canada

Represented by:

Ms Christina Foley

TB Programme Officer

Health and Nutrition Directorate (HAND)

200 Promenade Ave, du Portage

Gatineau

KIA 0G4 - Quebec

Canada

Corporate business sector

BioMèrieux

Mr Jean Francois de Lavison

International Affairs and Public Relation

Vice President

c/o Mérieux Alliance

17 rue Bourgelat

69009 Lyon

France

Communities Affected by TB

Mr Pervaiz Tufail (unable to attend)

Director

National Group of TB People-Pakistan

Flat 6, Block 1, PHA Flats

G-7/2

44000-Islamabad

Pakistan

Ms Carol Nawina Nyirenda(unable to attend)

1st Floor, Sanctuary House

9th Street, Kabwata

Lusaka

10101 Zambia

Represented by:

Mr Mayowa Joel

Program Director

Communication for Development Centre

Lagos

Nigeria

NGOS and Technical Agencies

Centers for Disease Control and Prevention

RADM Kenneth G. Castro, M.D.
Assistant Surgeon General, USPHS & CDC/ATSDR Lead, Commissioned Corps
Director, Division of TuberculosisElimination
NationalCenter for HIV, STD, and TB Prevention Coordinating Center for Infectious Diseases
Centers for Disease Control and Prevention,
Department of Health and Human Services

The Union

Dr Nils Billo (unable to attend)

Executive Director

International Union Against Tuberculosis and Lung Disease

France

Represented by

Dr Paula Fujiwara

Deputy Executive Director

KNCV

Dr Peter Gondrie

Executive Director

The Hague

The Netherlands

Operation ASHA

Mr Sandeep Ahuja

Chief Executive Officer

New Delhi

India

Special Invitees

UN Secretary General's Special Envoy

to Stop TB & Former President of the PortugueseRepublic

Dr Jorge Sampaio

Casa do Regalo

Tapada das Necessidades

1350-213 Lisbon

Portugal

Ms Helena Barroco

Office of the UN Secretary General's

Special Envoy

Portugal

UNAIDS

Mr Michel Sidibé

Executive Director

Joint United Nations Programme
on HIV/AIDS (UNAIDS)

Geneva

Other invitees/Observers

International Labour Organization

Dr Sophia Kisting

Director

Global Programme on AIDS

Mr Kofi Amekudzi

Technical Officer

Global Programme on Aids

ASTRA ZENECA

Mr Matti Ojanen

Corporate business sector Alternate Board Member &

Director, International Affairs &
Public Policy Group Public Affairs

London

United Kingdom

Stop TB Partnership Advocacy Advisory Committee

Dr Lee B. Reichman

Executive Director

New JerseyMedicalSchool Global Tuberculosis Institute

PO Box 1709

225 Warren Street

Newark, NJ07101-1709

Etats-Unis D'AMÉRIQUE

Ms Rachel A. Wilson
Director of Policy and Advocacy
Program for Appropriate Technology in Health (PATH)
1800 K St. NW, Suite 800
Washington, DC 20006
Etats-Unis D'AMÉRIQUE

DFID

Mr Sajil Liaqat

Public Health Advisor

Human Development Group

1 Palace StreetLondonSW1E 5HE

GATES Foundation

Ms Alexandra Melby Farnum

Program Officer

Global Health Policy & Advocacy

JohnsHopkinsSchool of Medicine

Professor William Bishai, MD, PhD
Co-Chair, Working Group on New TB Drugs &Co-Director
Center for Tuberculosis Research
Department. of Medicine
Division. of Infectious Diseases
Johns Hopkins School of Medicine
1550OrleansSt. Room 108
Baltimore, MD 21231-1001
United States of America

Kochon Foundation

Mr Baik In Hyun

Seoul

Republic of Korea

US Agency for International Development

Ms Susan Bacheller

TB Team Leader

Office of Health, Infectious Diseases
& Nutrition

Bureau for Global Health

3.06-80, 3rd floor

Ronald Reagan Building

Washington, DC 20523-5900

United States of America

UNDP

DrSabine Beckmann

Senior Programme Advisor

HIV/AIDS Group

Bureau for Development Policy

UNDP Office in Geneva

Switzerland

UNITAID

Dr Jorge Bermudez

Executive Secretary

Switzerland

Myanmar

Dr Win Maung

Director (Disease Control)

Department of Health

Ministry of Health

The Union of Myanmar

Aeras Global TB Vaccine Foundation

Ms Jennifer Woolley

Director, Advocacyand Resource Mobilization

Aeras Global TB Vaccine Foundation

Rockville, MDUSA

McKinsey & Company

Farhad Riahi

Boris Ewenstein

Arjen Iwema

Dr Jaap F. Broekmans
Former Executive Director KNCV
Koningin Emmakade 174
2518 JN - The Hague
PAYS-BAS

Ms Karin Holm

Independent Consultant

Geneva

WHO AFRO

Dr Rufaro. Chatora

Director

Division of Prevention and Control of AIDS, TB and Malaria

WHO EMRO

Dr.Akihiro Seita

Regional Adviser, TB

WHO EURO

Dr Lucica Ditiu

Medical Officer

WHO/Headquarters

20, avenue Appia

Geneva 27,1211, Switzerland

Dr.Hiroki Nakatani

Assistant Director General

HIV/AIDS, Tuberculosis, Malaria and Neglected Tropical Diseases (HTM)

DrHans V. Hogerzeil
Director
Essential Medicines and Pharmaceutical Policies

Dr Leopold Blanc

Coordinator, Stop TB Strategy

Stop TB Department

Dr Katherine Floyd

Coordinator, TB Monitoring and Evaluation

Stop TB Department

Dr Paul Nunn

TB Operations and Coordination
Stop TB Department

Ms Diana Weil

Coordinator, Policy and Strategy

Stop TB Department

Dr. Karin Weyer

Coordinator, TB Laboratory Strengthening

Stop TB Department

Stop TB Partnership Secretariat

Hosted and administered by WHO

20, avenue Appia

Geneva 27,1211, Switzerland

Dr Marcos Espinal

Executive Secretary

Ms Louise Baker

Senior Strategist

Ms Julia Geer

Team Leader, Branding, Marketing, Communications

Dr Giuliano Gargioni

Team Leader, Partnering & Social Mobilization

Mr Anant Vijay

Department & Partnership Resource Administrator

Mr Tom Moore

Interim Chief Operating Officer, GDF

Dr Christian Liendhardt

Research Movement

Mr Alan Esser

Governance Officer

Mr Homero Hernandez

Global Advocacy & Resource
Mobilization Officer